文献速递心脑血管急症

克隆性造血与动脉粥样硬化性心血管疾病风险

Clonal Hematopoiesis and Risk of Atherosclerotic Cardiovascular Disease.
PubMed 文献 · N Engl J Med · 2017-06-21
一句话结论在外周血细胞中检出CHIP与冠心病风险约翻倍相关,并在小鼠中加速动脉粥样硬化。

该研究通过全外显子测序检测外周血细胞中的CHIP,在4项病例对照研究(共4726例冠心病患者和3529名对照)中分析CHIP与冠心病的关联。在两个前瞻性队列的巢式病例对照分析中,CHIP携带者冠心病风险是非携带者的1.9倍(95%CI 1.4-2.7);在两个回顾性早发心肌梗死病例对照队列中,CHIP携带者心肌梗死风险是非携带者的4.0倍(95%CI 2.4-6.7)。DNMT3A、TET2、ASXL1和JAK2突变分别与冠心病相关,CHIP携带者冠状动脉钙化增加。在动脉粥样硬化易感小鼠中,移植Tet2敲除骨髓导致主动脉根部和主动脉粥样硬化病变增大,巨噬细胞趋化因子和细胞因子基因表达升高。

要点

  • 在两个前瞻性队列的巢式病例对照分析中,CHIP携带者冠心病风险是非携带者的1.9倍(95%CI 1.4-2.7)。
  • 在两个回顾性早发心肌梗死病例对照队列中,CHIP携带者心肌梗死风险是非携带者的4.0倍(95%CI 2.4-6.7)。
  • DNMT3A、TET2、ASXL1和JAK2突变分别与冠心病相关,CHIP携带者冠状动脉钙化增加。
  • 在动脉粥样硬化易感小鼠中,移植Tet2敲除骨髓导致主动脉根部和主动脉粥样硬化病变较对照骨髓增大。

适用人群与场景

  • 来自4项病例对照研究的4726例冠心病患者和3529名对照,包括两个前瞻性队列的巢式病例对照分析和两个回顾性早发心肌梗死病例对照队列。

诊断标准与关键阈值

  • CHIP定义为无其他血液学异常者中存在扩增的体细胞血细胞克隆。

研究设计与关键结果

  • 研究类型为病例对照研究加小鼠实验;在4项病例对照研究(共4726例冠心病患者和3529名对照)中,用全外显子测序检测外周血细胞CHIP。
  • 两个前瞻性队列的巢式病例对照分析中,CHIP携带者冠心病风险是非携带者的1.9倍(95%CI 1.4-2.7)。
  • 两个回顾性早发心肌梗死病例对照队列中,CHIP携带者心肌梗死风险是非携带者的4.0倍(95%CI 2.4-6.7)。
  • DNMT3A、TET2、ASXL1和JAK2突变分别与冠心病相关;CHIP携带者冠状动脉钙化增加。
  • 在动脉粥样硬化易感小鼠中,移植同源或异合Tet2敲除小鼠骨髓者主动脉根部和主动脉粥样硬化病变较接受对照骨髓者增大;Tet2敲除小鼠巨噬细胞中多种趋化因子和细胞因子基因表达升高。

证据类型、等级与局限

  • 证据类型:病例对照研究和小鼠实验;局限:原文未报告局限性。

对床旁实践的改变

  • 原文结论:外周血细胞中CHIP的存在与人类冠心病风险近乎翻倍相关,并在小鼠中加速动脉粥样硬化;作者未据此给出临床推荐。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: Clonal hematopoiesis of indeterminate potential (CHIP), which is defined as the presence of an expanded somatic blood-cell clone in persons without other hematologic abnormalities, is common among older persons and is associated with an increased risk of hematologic cancer. We previously found preliminary evidence for an association between CHIP and atherosclerotic cardiovascular disease, but the nature of this association was unclear.

METHODS: We used whole-exome sequencing to detect the presence of CHIP in peripheral-blood cells and associated such presence with coronary heart disease using samples from four case-control studies that together enrolled 4726 participants with coronary heart disease and 3529 controls. To assess causality, we perturbed the function of Tet2, the second most commonly mutated gene linked to clonal hematopoiesis, in the hematopoietic cells of atherosclerosis-prone mice.

RESULTS: In nested case-control analyses from two prospective cohorts, carriers of CHIP had a risk of coronary heart disease that was 1.9 times as great as in noncarriers (95% confidence interval [CI], 1.4 to 2.7). In two retrospective case-control cohorts for the evaluation of early-onset myocardial infarction, participants with CHIP had a risk of myocardial infarction that was 4.0 times as great as in noncarriers (95% CI, 2.4 to 6.7). Mutations in DNMT3A, TET2, ASXL1, and JAK2 were each individually associated with coronary heart disease. CHIP carriers with these mutations also had increased coronary-artery calcification, a marker of coronary atherosclerosis burden. Hypercholesterolemia-prone mice that were engrafted with bone marrow obtained from homozygous or heterozygous Tet2 knockout mice had larger atherosclerotic lesions in the aortic root and aorta than did mice that had received control bone marrow. Analyses of macrophages from Tet2 knockout mice showed elevated expression of several chemokine and cytokine genes that contribute to atherosclerosis.

CONCLUSIONS: The presence of CHIP in peripheral-blood cells was associated with nearly a doubling in the risk of coronary heart disease in humans and with accelerated atherosclerosis in mice. (Funded by the National Institutes of Health and others.).

来源:N Engl J Med,查看原文。版权归原作者所有。

参考来源

  1. Jaiswal S, Natarajan P, Silver AJ, et al. Clonal Hematopoiesis and Risk of Atherosclerotic Cardiovascular Disease. N Engl J Med. 2017. PMID: 28636844. doi:10.1056/NEJMoa1701719

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。